Carregant...
Pregabalin add‐on for drug‐resistant focal epilepsy
BACKGROUND: Epilepsy is a common neurological disease that affects approximately 1% of the UK population. Approximately one‐third of these people continue to have seizures despite drug treatment. Pregabalin is one of the newer antiepileptic drugs which have been developed to improve outcomes. This i...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2019
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6614921/ https://ncbi.nlm.nih.gov/pubmed/31287157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005612.pub4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|